RFK Says Trump Administration Could Provide Psychedelic Therapy To Military Veterans ‘Within 12 Months’

U.S. Department of Health and Human Services Secretary Robert F. Kennedy
Jr. says his agency is “absolutely committed” to expanding research on the
benefits of psychedelic therapy and, alongside of the head of the Food and
Drug Administration (FDA), is aiming to provide legal access to such
substances for military veterans “within 12 months.”

He also said that he speaks with U.S. Department of Veterans Affairs (VA)
Secretary Doug Collins about psychedelics policy issues “all the time.”

At a hearing before the House Energy & Commerce Committee on Tuesday, Rep.
Dan Crenshaw (R-TX) asked Kennedy about plans at HHS to advance
psychedelics studies, stressing the need to make the novel therapies
available to people with serious mental health conditions such as
post-traumatic stress disorder and depression.

“We are launching clinical trials now on that at FDA,” Kennedy said, adding
that there are currently “11 clinical trials at the VA going on at this
point—particularly for our service members and retired service members.”

“It’s critically important that we make sure that the science on this is
solid, and the preliminary results are very, very encouraging and it’s
something that we want to pursue,” he said, adding that he’s spoke with FDA
Commissioner Marty Makary, who told him “we don’t want to wait two years to
get this done.”

“These are people who badly need some kind of therapy. Nothing else is
working for them,” Kennedy said. “This line of therapeutics has tremendous
advantage, if given in a clinical setting, and we are working very hard to
make sure that that happens within 12 months.”

After Crenshaw brought up the fact that Congress has passed legislation
mandating that the Department of Defense (DOD) conduct clinical trials into
psychedelics for active duty military veterans, the health secretary also
noted that he’s “brought on personnel to liaison directly with VA,” and
that he speaks with Collins about it “all the time.”

“It’s something that both of us are deeply interested in,” he said.

To that end, Collins also disclosed in April that he had an “eye-opening”
talk with Kennedy about the therapeutic potential of psychedelic medicine.
And he said he’s open to the idea of having the government provide vouchers
to cover the costs of psychedelic therapy for veterans who receive services
outside of VA as Congress considers pathways for access.

Collins also recently visited a facility conducting research on psychedelics,
and he reiterated that it’s his “promise” to advance research into the
therapeutic potential of the substances—even if that might take certain
policy changes within the department and with congressional support.

The secretary’s visit to the psychedelics research center came about a
month after the VA secretary met with a military veteran who’s become an
advocate for psilocybin access to discuss the therapeutic potential of
psychedelic medicine for the veteran community.

Collins also briefly raised the issue in a Cabinet meeting with President
Donald Trump in April.

Psychedelic therapies show real promise for veterans and others battling
trauma.

We’re accelerating clinical trials at @US_FDA with urgency—and working to
ensure safe, science-based access within 12 months. Some therapies can’t
wait. pic.twitter.com/GDvccSleEJ

— Secretary Kennedy (@SecKennedy) June 24, 2025

Meanwhile last month, bipartisan congressional lawmakers asked the VA head
to meet with them to discuss ways to provide access to psychedelic medicine
for military veterans.

In a letter sent to Collins, Reps. Lou Correa (D-CA) and Jack Bergman
(R-MI)—co-chairs of the Congressional Psychedelic Advancing Therapies
(PATH) Caucus—said they were “encouraged by your recent remarks about the
importance of pursuing research into psychedelic treatments and other
alternative treatments to improve Veterans’ care.”

Correa and Bergman separately introduced a bill in April to provide $30
million in funding annually to establish psychedelics-focused “centers for
excellence” at VA facilities, where veterans could receive novel treatment
involving substances like psilocybin, MDMA and ibogaine.

Bergman has also expressed optimism about the prospects of advancing
psychedelics reform under Trump, arguing that the administration’s efforts
to cut spending and the federal workforce will give agencies “spines” to
tackle such complex issues.

Kennedy, for his part, also said in April that he had a “wonderful
experience” with LSD at 15 years old, which he took because he thought he’d
be able to see dinosaurs, as portrayed in a comic book he was a fan of.

Last October, Kennedy specifically criticized FDA under the prior
administration over the agency’s “suppression of psychedelics” and a
laundry list of other issues that he said amounted to a “war on public
health” that would end under the Trump administration.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

In December, VA separately announced that it’s providing $1.5 million in
funding to study the efficacy of MDMA-assisted therapy for veterans with
PTSD and alcohol use disorder (AUD).

Last year, VA’s Yehuda also touted an initial study the agency funded that
produced “stunning and robust results” from its first-ever clinical trial
into MDMA therapy.

In January, former VA Under Secretary for Health Shereef Elnahal said that
it was “very encouraging” that Trump’s pick to have Kennedy lead HHS has
supported psychedelics reform. And he hoped to work with him on the issue
if he stayed on for the next administration, but that didn’t pan out.

DEA Judge Sides With Agency On Proposal To Ban Two Psychedelics Despite
Challenge From Scientific Researchers

The post RFK Says Trump Administration Could Provide Psychedelic Therapy To
Military Veterans ‘Within 12 Months’ appeared first on Marijuana Moment.